BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 1444229)

  • 21. A new steroidal alkylating agent with improved activity in advanced murine leukemias.
    Catsoulacos P; Politis D; Wampler GL
    Cancer Chemother Pharmacol; 1979; 3(1):67-70. PubMed ID: 535128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
    Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
    Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study on cytogenetic damage induced by homo-aza-steroidal esters in human lymphocytes.
    Mourelatos D; Papageorgiou A; Boutis L; Catsoulacos P
    Mutat Res; 1995 Feb; 334(1):19-22. PubMed ID: 7528334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced cytogenetic and antineoplastic effects by the combined action of two esteric steroidal derivatives of nitrogen mustards.
    Papageorgiou A; Nikolaropoulos SS; Arsenou ES; Karaberis E; Mourelatos D; Kotsis A; Chryssogelou E
    Chemotherapy; 1999; 45(1):61-7. PubMed ID: 9876211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid anticancer compounds. Steroidal lactam esters of carboxylic derivatives of N,N-bis (2-chloroethyl) aniline (review).
    Catsoulacos P; Catsoulacos D
    Anticancer Res; 1991; 11(5):1773-7. PubMed ID: 1768051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid aza-steroid alkylators in the treatment of colon cancer.
    Trafalis DT
    Cancer Lett; 2006 Nov; 243(2):202-10. PubMed ID: 16412564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid and [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
    Catsoulacos P; Politis D; Wampler GL
    Cancer Chemother Pharmacol; 1983; 10(2):129-32. PubMed ID: 6831626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
    Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo antitumor activity of 5-hydroxy-6-[N,N-bis(2-chloroethyl)aminomethyl]naphthalene-1,8- carbolactone.
    Riondel J; Boitard M; Bouaziz Z; Fillion H
    Pharmazie; 1992 Jan; 47(1):67-8. PubMed ID: 1608991
    [No Abstract]   [Full Text] [Related]  

  • 31. Antitumor activity of patulin and structural analogs.
    Seigle-Murandi F; Steiman R; Krivobok S; Beriel H; Benoit-Guyod JL
    Pharmazie; 1992 Apr; 47(4):288-91. PubMed ID: 1518888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further study on the antitumor activity of a homo-aza-steroidal ester of p-N,N-bis(2-chloroethyl)aminophenylacetic acid.
    Catsoulacos P
    J Pharm Sci; 1990 Nov; 79(11):1040. PubMed ID: 2292767
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
    Karaivanova MH; Zakhariev SG; Golovinsky EV
    Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
    Kato T; Fukushima M; Kurozumi S; Noyori R
    Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antileukemic and cytogenetic effects of modified and non-modified esteric steroidal derivatives of 4-methyl-3-bis(2-chloroethyl)amino benzoic acid (4-Me-CABA).
    Fousteris MA; Koutsourea AI; Arsenou ES; Papageorgiou A; Mourelato D; Nikolaropoulos SS
    Anticancer Res; 2002; 22(4):2293-9. PubMed ID: 12174917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of pre-activated analogs of cyclophosphamide (NSC-26271).
    Montgomery JA; Struck RF
    Cancer Treat Rep; 1976 Apr; 60(4):381-93. PubMed ID: 945126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
    Wieczorek J; PeczyƄska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroidal esters of the aromatic nitrogen mustard 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoic acid (2-PHE-BU): synthesis and in-vivo biological evaluation.
    Papaconstantinou IC; Fousteris MA; Koutsourea AI; Pairas GN; Papageorgiou AD; Nikolaropoulos SS
    Anticancer Drugs; 2013 Jan; 24(1):52-65. PubMed ID: 23187313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of an homo-aza-steroidal ester on estrogen receptor.
    Leclercq G; Devleeschouwer N; Pairas G; Camoutsis C; Catsoulacos P
    Methods Find Exp Clin Pharmacol; 1983; 5(6):365-7. PubMed ID: 6621181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.